Unscrubbed Aldoxorubicin Phase 3 Pivotal Trial Data Approaches Maturity: The Dirty Truth Seeking Alpha, 02 Dec 2016 CytRx Corporation (NASDAQ: CYTR ) has released unscrubbed data of its phase 3 pivotal trial for Aldoxorubicin as a monotherapy…